Benzinga | Nov 5, 2021 09:21AM EDT

Axonics Modulation Tech Q3 EPS $(0.38) Beats $(0.43) Estimate, Sales $46.90M Miss $48.97M Estimate

Axonics Modulation Tech (NASDAQ:AXNX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.43) by 11.63 percent. This is a 58.33 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $46.90 million which missed the analyst consensus estimate of $48.97 million by 4.23 percent. This is a 33.08 percent increase over sales of $35.24 million the same period last year.